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ABSTRACT
Soluble functional proteins may transform into insol-
uble amyloid fibrils that deposit in a variety of tis-
sues. Amyloid formation is a hallmark of age-related
degenerative disorders. Perhaps surprisingly, amy-
loid fibrils can also be beneficial and are frequently
exploited for diverse functional roles in organisms.
Here we introduce AmyPro, an open-access database
providing a comprehensive, carefully curated collec-
tion of validated amyloid fibril-forming proteins from
all kingdoms of life classified into broad functional
categories (http://amypro.net). In particular, AmyPro
provides the boundaries of experimentally validated
amyloidogenic sequence regions, short descriptions
of the functional relevance of the proteins and
their amyloid state, a list of the experimental tech-
niques applied to study the amyloid state, important
structural/functional/variation/mutation data trans-
ferred from UniProt, a list of relevant PDB structures
categorized according to protein states, database
cross-references and literature references. AmyPro
greatly improves on similar currently available re-
sources by incorporating both prions and functional
amyloids in addition to pathogenic amyloids, and al-
lows users to screen their sequences against the en-
tire collection of validated amyloidogenic sequence
fragments. By enabling further elucidation of the se-
quential determinants of amyloid fibril formation, we
hope AmyPro will enhance the development of new
methods for the precise prediction of amyloidogenic
regions within proteins.
INTRODUCTION
Proteins are crucial macromolecules mediating most cellu-
lar functions and the majority of them have well-defined
folded structures to serve these roles. If they fail to adopt or
to remain in their native structural states and misfold, they
are prone to aggregate and can form amyloid fibrils that are
associated with a number of degenerative human disorders
such as type II diabetes, Huntington’s and Alzheimer’s dis-
eases and systemic amyloidosis (1–4). Amyloids are non-
covalent fibrillar structures of extended, inter-molecularly
hydrogen bonded -sheets that laterally self-assemble to
yield insoluble, twisted fibrils typically of 10 nm in diam-
eter, in which they are oriented perpendicular to the fibril
axis. Due to this arrangement, the amyloid fold is often re-
ferred to as a cross -sheet structure (5,6). Multiple recent
lines of evidence suggest that the amyloid state can also be
beneficial for different functional purposes (7,8), such as
bacterial and fungal biofilm formation (9–12), antimicro-
bial activity (13,14), the storage of peptide hormones (15)
and the formation of the zona pellucida for the protection
of mammalian and fish oocytes (16,17), among others. Be-
sides these functional benefits, another reason why aggre-
gation and amyloid fibril formation are maintained during
evolution is that the regions involved are often part of the
hydrophobic core of these proteins, and are thus required
for them to fold correctly (18,19). Although amyloids play a
key role in numerous important human diseases, the molec-
ular mechanisms, the effects of mutations and changes in
cellular milieu, the kinetics and the potential functional-
evolutionary driving forces of amyloid fibril formation are
only sparsely understood.
The propensity for amyloid formation is encoded in the
protein sequence, but a comprehensive, curated and regu-
larly updated database that stores known amyloid precur-
sor proteins and their amyloidogenic regions is still lack-
ing. The AMYPdb database (20) which aimed to fulfil this
*To whom correspondence should be addressed. Tel: +44 1223 267 823; Fax: +44 1223 213 556; Email: ritapancsa@gmail.com
Correspondence may also be addressed to Mihaly Varadi. Tel: +44 1223 494 278; Fax: +44 1223 494 468; Email: mvaradi@ebi.ac.uk
C© The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which
permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact
journals.permissions@oup.com
Downloaded from https://academic.oup.com/nar/article-abstract/46/D1/D387/4508877
by Hungary EISZ Consortium user
on 27 February 2018
D388 Nucleic Acids Research, 2018, Vol. 46, Database issue
role, contains only 33 amyloid precursor proteins forming
mainly pathogenic amyloids in human, and was not up-
dated since 2008. Other databases store information on the
amyloid fibril-forming capacities of short peptides, for in-
stance WaltzDB (21), while AmyLoad contains only a few
amyloidogenic protein fragments (22). The recently pub-
lished Curated Protein Aggregation Database (CPAD, (23))
is an integrated resource of aggregation data, but only stores
the 33 amyloid precursor proteins that are also contained by
the out-of-date AMYPdb, without any protein structure or
amyloid classification information.
In order to offer a more comprehensive and progres-
sive online resource, we have collected proteins that have
been demonstrated to form either pathogenic or functional
amyloid fibrils or prions, with special focus on their amy-
loidogenic sequence regions through manually curated in-
depth literature mining. This functionally classified set of
amyloid-forming proteins is made available in AmyPro and
offers a significantly more detailed view than its peers, as
it already contains 143 entries as of September 2017, out
of which for 127 the amyloidogenic regions or prion do-
mains are also defined. Our data collection pipeline en-
ables continuous updates of the database through dedicated
searches of the recent literature, in addition to inviting the
scientific community to contribute to the project by sub-
mitting their published data via our user-friendly submis-
sion interface. AmyPro provides comprehensive informa-
tion on the entry sequences, including the precursor pro-
teins, experimentally validated amyloidogenic sequence re-
gions, a short description of the functional relevance of their
soluble and amyloid states, a list of the experimental tech-
niques used to discover and investigate the amyloid state,
structural/functional/variation/mutation annotations ob-
tained from UniProt (24) and relevant, classified structures
linking to the PDBe/RCSB/PDBj entry pages of the entries,
with representative structures also displayed as static pic-
tures for the fibrillar and/or soluble states with amyloido-
genic regions highlighted in color.Additionally, AmyPro of-
fers a sequence screening service allowing the users to screen
their sequences of interest for matching fragments with the
validated amyloidogenic regions stored in the database.
MATERIALS AND METHODS
Data collection and classification
The initial dataset incorporated the curated data of 33
amyloid precursor proteins from the Supplementary Data
of Tsolis et al. (25). For many of these, e.g. calcitonin,
apolipoprotein A-I, transthyretin and cystatin C, the anno-
tated amyloidogenic regions were also updated based on re-
cently published analyses (26–30). We then collected other
proteins from the literature for which amyloid fibril forma-
tion was experimentally demonstrated, with the only ex-
ception of different variants of antibody light chains that
are numerous and are already available in ALBase main-
tained by Boston University (http://albase.bumc.bu.edu/
aldb/). The amyloidogenic sequence regions were confirmed
for most of the proteins, although in some cases this infor-
mationwasmissing or the proposed regionwas only defined
based on predictions. Such predictions were deemed to be
of lower reliability, and thus for these cases the amyloido-
genic regions were not defined on a residue level in AmyPro.
Sixteen entries are for proteins that are known to be amy-
loidogenic, but their amyloid forming regions are not yet de-
fined. It is also important to note that for amyloid-forming
proteins and peptides that are <45 residues in length, for
instance peptide hormones (15) and antimicrobial peptides
(13,14), we did not necessarily require definition of an amy-
loidogenic region, but accepted the entire sequence as amy-
loidogenic. In the case of prions, we accepted full prion do-
mains as amyloidogenic regions and also indicated shorter
segments of the domain if those were explicitly defined as
amyloidogenic core regions. AmyPro provides a flag to eas-
ily identify entries with prion domains in order to help users
and method developers to distinguish them from better re-
solved amyloidogenic regions, since those display distinctly
different length distributions and amino acid compositions
(see the Stats page of AmyPro).
The database stores the protein sequences investigated in
the experiments addressing amyloid formation, which of-
ten lack initiator methionines, signal peptides and propep-
tides, and may comprise only a single domain compared
to the corresponding UniProt entries (24). UniProt residue
boundaries and information on the corresponding precur-
sor protein are indicated. In a few cases where the wild-type
protein does not form amyloid, but amutant form does (31–
34), we included themutated sequence into the database and
clearly indicated the change compared to the corresponding
UniProt entry sequence. The boundaries of amyloidogenic
regions are provided with regard to both the displayed pro-
tein sequences and the corresponding UniProt entries. The
collected amyloidogenic proteins were screened against the
Protein Data Bank (35) to obtain available structural infor-
mation on them. Similarly, they were mapped onto UniProt
(24), from where the relevant sections of feature tables were
retrieved, including e.g. variation data, providing detailed
information on relevant disease mutations.
The collected proteins were classified into five broad cat-
egories based on the proposed functions of their amyloid
states in the literature: (i) pathogenic amyloids that are as-
sociated with known human diseases, (ii) functional amy-
loids that confer well-described functional benefits to the
organism, (iii) functional prions that are self-propagating
amyloid forms of proteins that confer functional benefits to
the organism, (iv) amyloids whose functional relevance is
not known and (v) biologically not relevant amyloids that
were observed under conditions whose biological relevance
is questionable. Besides the classification, a short descrip-
tion is provided for each entry that explains the function of
the protein and the proposed role of its amyloid state.
Implementation
AmyPro is implemented as an AngularJS web application
fueled by the underlying data stored in multi-level JSON.
The advantages of this technology are that it scales well
with increasing data traffic and it enables responsive and
dynamic behavior onmultiple media, such as personal com-
puters and hand-held devices.
Each data record contains an entry ID, cross-references
to other resources (PDBe (35), UniProt (24), PubMed),
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source organism, protein name and sequence, alternative
names for both the investigated and the parent protein (if
relevant) and the recommended amyloid name (if relevant),
mutations (if relevant), functional classification, a list of the
experimental techniques applied to study the amyloid state
and the actual amyloidogenic sequence region(s). Where
available, determined structures grouped according to rel-
evant protein states are also provided as direct links to the
corresponding wwPDB pages.
Data can be accessed via either the online user interface,
direct URLs serving up FASTA or raw TXT formats and
a RESTful API serving JSON, for example http://amypro.
net/data/entries/AP00017.txt directly provides the data of
entry AP00017 in TXT format, and http://amypro.net/data/
entries/AP00007.json displays entry AP00007 in JSON.
RESULTS
The AmyPro database (http://amypro.net) greatly improves
accessibility to amyloid data both in a qualitative and quan-
titative sense, by providing 143 carefully curated, experi-
mentally validated amyloid fibril-forming proteins (as of
September 2017), including 127 with defined amyloidogenic
regions totaling 5819 residues (2587 in prion domains and
3232 in annotated shorter amyloidogenic fragments). It is
important to emphasize that AmyPro only contains aggre-
gating proteins that form amyloids/prions, but it is not in-
tended to host proteins implicated in phase separation or
in forming amorphous aggregates. Data collection will con-
tinue in order to maintain a regularly updated online re-
source, with the goal of periodic releases twice every year.
To this end, we also kindly invite the scientific community
to contribute by sending data using our online submission
interface (http://www.amypro.net/#/submit). AmyPro cur-
rently includes 57 pathogenic and 54 functional amyloids,
17 functional prions and 15 cases where the role of the
amyloid state is not known or has only been observed un-
der non-native conditions and thus was considered as bio-
logically not relevant. Apolipoprotein A-I is an illustrative
example (http://www.amypro.net/#/entries/AP00003) of the
increased quality of our database: the amyloidogenic region
was previously loosely defined to residues 1-93 (25), but is
now redefined to a 14-residue stretch following a recent pub-
lication (30).
User interface and website features
The online user interface of AmyPro offers convenient ways
to access the amyloidogenic data. The database can be
browsed and searched by clicking on the respective button
on the top navigation bar.While browsing, the displayed en-
try list can be filtered by category (pathogenic, functional
prion, functional amyloid, unknown, biologically not rel-
evant) and by typing in filtering terms, such as a species-
or protein name. Similarly, searching can be performed by
typing in a search term, and then the results may be fur-
ther refined by adding species name or category. Examples
of search terms are AmyPro or UniProt IDs, protein/gene
names or species.
Both browsing and searching results are displayed as lists
of relevant entries arranged as a table. Clicking on any row
will direct the user to the dedicated entry page. Clicking on
the plus signs on the left hand side allows the user to se-
lect multiple entries, and then perform a batch download in
JSON format by pressing the ‘Download selected’ button.
Searching can also be performed using an input se-
quence on the search screen. Pasting a sequence and press-
ing ‘Match’ will run a screening process and return all those
entries where at least six consecutive residuesmatch any seg-
ment within the user input. Again, clicking on any row in
the results table will lead to the entry page.
In addition to accessing specific entries, the complete
dataset is also available for download in three different data
formats. Pressing the ‘Download’ button on the top naviga-
tion menu displays a drop-down menu from which the data
format can be selected. AmyPro is currently available for
download in JSON, FASTA and raw TXT formats.
We invite the scientific community to submit their own
published data by filling in our user-friendly online submis-
sion form. Clicking on the ‘Submit’ button on the top nav-
igation bar directs the user to this form.
Finally, we provide database statistics (sequence length
distributions and amino acid compositions) on the ‘Stats’
page, and an online documentation of all the functionalities
of AmyPro on the ‘Help’ page, both accesses using the top
navigation menu.
Accession pages
Each database entry can be investigated in detail by ac-
cessing its dynamically generated entry page via browsing,
searching or direct URL links (Figure 1).
On the top of each entry page, the entry ID is displayed
along with the name of the protein, the International Soci-
ety ofAmyloidosis (ISA) recommended name of the derived
amyloid (36) with smaller letters (if relevant), and the classi-
fication of the regions (pathogenic, functional prion, func-
tional amyloid, unknown, biologically not relevant). This
section also provides the alternative names, the source or-
ganism and the precursor/parent protein with its respec-
tive alternative names (where relevant), the related pub-
lications and direct links to download the data in TXT,
FASTA or JSON formats. Below this section a brief, amy-
loid state-centric description of the entry is provided fol-
lowed by the corresponding UniProt functional description
that describes the parent protein if not explicitly stated oth-
erwise. The next two sections provide information on the
functional classification of the amyloid form and a list of the
experimental techniques by which it was discovered/ stud-
ied in the listed publications.
The investigated protein sequence (as provided by the au-
thors) is displayed below, with the corresponding UniProt
accession and residue boundaries provided in brackets and
amyloidogenic regions colored according to their category’s
color code.
Below the data visualization, the actual amyloidogenic
region and prion domain sequences are displayed in ad-
dition to their residue indices (corresponding to the en-
try sequence and the UniProt sequence) and links to the
corresponding literature references. If in different publica-
tions overlapping segments were claimed amyloidogenic,
those were merged to obtain our AmyPro amyloidogenic
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Figure 1. AmyPro entry screen. AmyPro provides all the relevant information on specific entry pages. In addition to displaying data, these pages also offer
direct download links (TXT, FASTA and JSON formats) as well as data visualization by mapping the amyloidogenic regions or prion domain of the given
entry protein onto available structural data and functional annotations (imported from PDBe and UniProt, respectively).
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segments and all the supporting publications are provided.
The bottom section of the entry pages show important
UniProt features after pressing the ‘Click to load Feature
Viewer’ button, using the recently released visualization
tool of UniProt, ProtVista (37), extending it with AmyPro
data. Using this tool, the AmyPro sequence and amyloido-
genic regions can easily be compared to various features,
such as protein processing data, structural features, PTMs
and variations (each corresponding to an extendable line
in the table). When applicable, relevant PDB IDs grouped
into fibrillar (including structures of short cross- spines
with varied steric zippers), precursor and soluble states,
also distinguishing wild-type, segment, mutant and com-
plex forms within the soluble state are listed below. These
PDB IDs link to the corresponding PDBe/RCSB/PDBj
entry pages. Representative PDB structures of the soluble
wild-type and/or fibrillar forms are also displayed (in the
absence of the full-length soluble wild-type sequence, a rel-
evant segment of the protein may be displayed), with the
amyloidogenic regions highlighted. Finally, at the bottom
of the entry page, a web component is displayed that maps
every available PDB structure to the UniProt ID, while also
displaying Pfam entities. This web component was devel-
oped and ismaintained by PDBe in their component library
(https://www.ebi.ac.uk/pdbe/pdb-component-library/).
DISCUSSION
AmyPro is a novel, carefully curated database of amyloid
precursor proteins and their amyloidogenic sequence re-
gions that aims to provide an up-to-date view of the entire
amylome. It contains significantly more amyloid-forming
proteins than any of its peers, mainly due to incorporating
validated functional amyloids and prion proteins from all
kingdoms of life for the first time. AmyPro will be regu-
larly updated, relying not only on data submissions from
the research community but also on regular internal up-
dates based on scanning newly published amyloid literature.
By storing the most comprehensive list of amyloid fibril-
forming proteins published so far in combination with a
useful set of features facilitating their efficient analysis, we
anticipate AmyPro to become central to amyloid research,
and to have major impact on its progress. To achieve this
goal we are dedicated to ensure the long-term availability
of the database.
In particular, AmyPro has huge potential in helping to
elucidate the sequential determinants of amyloid fibril for-
mation. Furthermore, the provided functional classifica-
tions might enable refining these sequential determinants
according to the biological functions of amyloid fibrils and
understanding the functional relevance of their differences.
Better definition of the sequence determinants of amyloid
fibril formation will also help in understanding and pre-
dicting the effects of mutations within amyloidogenic se-
quence fragments and relate them to the underlyingmolecu-
lar mechanisms, which in turn may enable the development
of novel methods for more accurate computational identifi-
cation of amyloidogenic regions within proteins.
AVAILABILITY
AmyPro is available at http://amypro.net and is open to sub-
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